Psoriasis clinic was started in November 1999. Patients who are candidates for this clinic include: 

1) Severe psoriasis whether, generalized plaque psoriasis, erythrodermic or pustular psoriasis, who need rapid clearance of their disease. 

2) Moderately severe psoriasis not responding to Phototherapy (PUVA or UVB).

 3) Palmoplantar psoriasis not responding to conventional therapy. 

The treatment protocol is tailored to each patient and treatment options include immunosuppresants like Methotrexate, Cyclosporine, Acitretin, Mycophenolate mofetil and biological drugs like Infliximab (Remicade), Adalimumab (Humira),  Etanercept (Enbrel), Ustekinumab (Stelara), Ixekizumab (Taltz), Secukinumab (Cosentyx), Guselkumab (Tremfya), Risankizumab-rzaa (Skyrizi) and others.